Imaging of Coronary Plaques in Participants Treated With Evolocumab

Autores
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2018

Este artículo no está incluido en ninguna revisión sistemática

Cargando información sobre las referencias
This study seeks to identify morphologic changes, such as increase in FCT in atherosclerotic plaques associated with treatment with evolocumab and maximally tolerated statin therapy with or without additional lipid‐modifying medication in patients presenting with NSTE‐ACS using optical coherence tomography (OCT; primary, secondary, and exploratory endpoints).
Epistemonikos ID: 2be8a107e263e869ea1c13b7b1d84a3da0712b79
First added on: May 21, 2024